Home/Filings/4/0001209191-18-057797
4//SEC Filing

Went Gregory T 4

Accession 0001209191-18-057797

CIK 0001328143other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 6:04 PM ET

Size

5.6 KB

Accession

0001209191-18-057797

Insider Transaction Report

Form 4
Period: 2018-11-07
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2018-11-07$12.98/sh+3,850$49,956199,242 total(indirect: By Trust)
Holdings
  • Common Stock

    182,610

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeother

Related Parties

1
  • filerCIK 0001604541

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 6:04 PM ET
Size
5.6 KB